CHARACTERIZATION OF CONJUGATED METABOLITES OF A NEW ANGIOTENSIN-II RECEPTOR ANTAGONIST, CANDESARTAN CILEXETIL, IN RATS BY LIQUID-CHROMATOGRAPHY ELECTROSPRAY TANDEM MASS-SPECTROMETRY FOLLOWING CHEMICAL DERIVATIZATION
T. Kondo et al., CHARACTERIZATION OF CONJUGATED METABOLITES OF A NEW ANGIOTENSIN-II RECEPTOR ANTAGONIST, CANDESARTAN CILEXETIL, IN RATS BY LIQUID-CHROMATOGRAPHY ELECTROSPRAY TANDEM MASS-SPECTROMETRY FOLLOWING CHEMICAL DERIVATIZATION, Journal of mass spectrometry., 31(8), 1996, pp. 873-878
Combined liquid chromatography and electrospray mass spectrometry (LC/
ESI-MS) and tandem mass spectrometry (MS/MS) were used for the charact
erization of the conjugated metabolites (glucuronides) of a new angiot
ensin II receptor antagonist, candesartan cilexetil (TCV-116; (+/-)-1-
(cyclohexyloxycarbonyloxy)ethyl henyl-4-yl]methyl}-1H-benzimidazole-7-
carboxylate) in the plasma and bile of rats given the drug. The glucur
onides of the active component, M-I (candesartan), in rat plasma and b
ile were positional isomers with respect to the binding site of glucur
onic acid The site of glucoronidation in M-I was not directly identifi
ed by mass spectrometry. However, the structure of the isomers could b
e elucidated by the MS/MS analysis of dimethylated glucuronides prepar
ed by the reaction of glucuronide isomers with diazomethane: N-glucuro
nide of M-I (M-I-NG) in the plasma and acyl glucuronide (M-I-AG) in th
e bile. The results obtained in this study indicated that LC/ESI-MS/MS
analysis provides the detailed structure of conjugated metabolite by
simple chemical derivatization.